Top 50 Biotechnology VC Funds & Investors in Hong Kong (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Loyal VC
VC Fund
|
3 | United States, Canada, United Kingdom | Pre-Seed, Seed | Artificial Intelligence, Software, E-Commerce | $78k–$3.1M |
|
Lever VC
VC Fund
|
3 | United States, China, United Kingdom | Seed, Series A, Pre-Seed | Food and Beverage, Biotechnology, Food Processing | $500k–$24M |
|
Alibaba Entrepreneurs Fund
VC Fund
|
3 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Software, E-Commerce, Artificial Intelligence | $510k–$150M |
|
Arkansas Development Finance Authority
VC Fund
|
2 | United States, Hong Kong | Seed, Pre-Seed | Medical, Biotechnology, Fashion | |
|
Artesian VC
VC Fund
|
2 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Bold Capital Partners
VC Fund
|
2 | United States, Hong Kong, India | Series A, Series B, Seed | Health Care, Software, Biotechnology | $2M–$58M |
|
CPT Capital
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Seed, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Simmons Foods
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
FHB Ventures
VC Fund
|
2 | Hong Kong, United States | Seed, Series A, Series B | Medical, Agriculture, Biotechnology | |
|
PT Medion
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
Whist Subholdings
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
Gobi Partners GBA
VC Fund
|
2 | Hong Kong, China | Seed, Angel, Series A | Biotechnology, Solar, Energy | $2M–$13M |
|
Prox Ventures
VC Fund
|
1 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $1.9M–$28M |
|
Coent Venture Partners
VC Fund
|
1 | Taiwan, China, Hong Kong | Seed, Series A | Apps, SaaS, Travel | $275k–$800k |
|
FutureX Capital
VC Fund
|
1 | China, United States, Hong Kong | Seed, Series A, Series B | Artificial Intelligence, Manufacturing, Health Care | $3.2M–$110M |
|
Longevity Vision Fund
VC Fund
|
1 | United States, Hong Kong, Isle of Man | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $37M–$300M |
|
Proxima Ventures Ltd
VC Fund
|
1 | China, United States, Israel | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $213k–$150M |
|
WI Harper Group
VC Fund
|
1 | United States, Taiwan, China | Series A, Seed, Series B | Software, Health Care, Biotechnology | $1.1M–$41M |
|
208 Seed Ventures
VC Fund
|
1 | Hong Kong | Seed | Biotechnology | |
|
ETP Ventures
VC Fund
|
1 | China, Hong Kong | Seed, Angel, Series A | Health Care, Biotechnology, Medical | |
|
Pavilion Capital
VC Fund
|
1 | United States, Japan, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Information Technology | $6M–$723M |
|
The International Medical
VC Fund
|
1 | Hong Kong | Seed | Medical, Hospitality, Biotechnology | |
|
Apis Partners
VC Fund
|
1 | India, South Africa, Hong Kong | Private Equity, Series B | Financial Services, Payments, FinTech | |
|
StartUp Health
VC Fund
|
1 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Alon Capital Ltd
VC Fund
|
1 | Hong Kong | Series A | Biopharma, Life Science, Biotechnology | |
|
Tiger Jade Capital
VC Fund
|
1 | Hong Kong | Series A | Biopharma, Life Science, Biotechnology | |
|
Human Longevity and Performance Impact Venture Fund
VC Fund
|
1 | Hong Kong | Series A | Health Care, Biotechnology | |
|
Venturra
VC Fund
|
1 | Indonesia, Singapore, Vietnam | Seed, Series A, Series B | E-Commerce, Financial Services, Software | $1M–$60M |
|
AEF Greater Bay Area Fund
VC Fund
|
1 | Hong Kong, China, Macao | Seed, Series A, Series B | Biotechnology, Sports, Boating | $2.5M–$28M |
|
Vectr
VC Fund
|
1 | United States, Hong Kong, Singapore | Seed, Series A, Series B | FinTech, Financial Services, Artificial Intelligence | $547k–$70M |
|
WuXi AppTec
VC Fund
|
1 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Pharmaceutical, Health Care | $6M–$130M |
|
Capital Union Investments
VC Fund
|
1 | Hong Kong, United States | Seed, Series A | SaaS, Genetics, Software | $2M–$10M |
|
S2G Investments
VC Fund
|
1 | United States, Canada, Israel | Series A, Series B | Agriculture, Food and Beverage, Biotechnology | $4M–$100M |
|
Thia Ventures
VC Fund
|
1 | United States, France, Denmark | Series A, Seed, Series B | Biotechnology, Health Care, Food and Beverage | $3.3M–$53M |
|
AngelHub
VC Fund
|
1 | Hong Kong, United States, Israel | Seed, Series A, Pre-Seed | FinTech, Software, Blockchain | $1.1M–$5M |
|
Ping An
VC Fund
|
1 | China, United States, Japan | Series A, Series E | Health Care, FinTech, Finance | $1.4M–$300M |
|
LongeVC
VC Fund
|
1 | United States, Canada, Estonia | Seed, Series A | Biotechnology, Health Care, Therapeutics | $1.5M–$7M |
|
Particle Accelerator Limited (ParticleX)
VC Fund
|
1 | Hong Kong, United States, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Information Technology, Software | $1M–$6.9M |
|
ASBV
VC Fund
|
1 | China, Australia, Hong Kong | Seed, Series A, Angel | Health Care, Medical, Biotechnology | $425k–$31M |
|
Emerging Technology Partners
VC Fund
|
1 | China, United States, Hong Kong | Series A, Series B | Biotechnology, Medical, Health Care | $3.4M–$9.9M |
|
Gobi Partners
VC Fund
|
1 | China, Malaysia, Singapore | Series A, Seed, Series B | E-Commerce, Financial Services, Internet | $800k–$37M |
|
Hillhouse Investment
VC Fund
|
1 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$230M |
|
Formic Ventures
VC Fund
|
1 | United States, United Kingdom, Hong Kong | Seed, Series A | Biotechnology, Health Care, Biopharma | $1.3M–$61M |
|
Juvenescence
VC Fund
|
1 | United States, Hong Kong, Isle of Man | Series A, Debt Financing | Biotechnology, Pharmaceutical, Health Care | $3M–$19M |
|
Hillhouse Ventures
VC Fund
|
1 | China, Singapore, Norway | Series A, Series B, Seed | Manufacturing, Biotechnology, Health Care | $10M–$120M |
|
Merrill Lynch
VC Fund
|
1 | United States, India, United Kingdom | Series B, Series C | Software, Information Technology, Internet | $10M–$85M |
|
Beyond Ventures
VC Fund
|
1 | China, Hong Kong, Canada | Seed, Series A | Information Technology, Artificial Intelligence, Health Care | $720k–$138M |
|
A-Level Capital
VC Fund
|
1 | United States, Hong Kong | Seed, Series A | Health Care, Medical, SaaS | $100k–$6M |
|
China Venture Capital
VC Fund
|
1 | China, Hong Kong, United States | Angel, Series B | Manufacturing, Biotechnology, Medical | $425k–$72M |
|
Good Startup
VC Fund
|
1 | United States, Israel, Canada | Seed, Series A, Pre-Seed | Food and Beverage, Biotechnology, Food Processing | $1.9M–$12M |
| Access all 106 VC funds in Hong Kong Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, E-Commerce
- Stage:Pre-Seed, Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 146
- Round size: Seed $78k–$3.1M; Pre-Seed $110k–$1M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Peerby Classic — Borrow and rent goods from others nearby - affordable, convenient and green. Tools, bikes, party equipment, electronics and more. Try it now.
- Zobi — Zobi’s not just Artificial Intelligence, it’s Home Intelligence. Our smart, brand-agnostic solutions take a holistic view of homes - people, devices, networks, habits. They build an anonymous profile for each home, then use that intel to spot unusual behaviour and stop cybercriminals.
- Finverity — Finverity provides technology, working capital and expertise to give banks, NBFIs, financiers and companies a strategic advantage in supply chain finance
Lever VC is a U.S.-Hong Kong venture capital fund founded by Managing Partner Nick Cooney and investing in early stage companies in the alternative protein sector (plant-based and “clean”/cell-based meat, egg and dairy companies). Lever VC operates globally, with offices in Hong Kong and the U.S. and staff in the US, Hong Kong, Europe, andIsrael. Entrepreneurs and startups interested in connecting with Lever VC about possible investment can reach the team and submit information about their company at http://www.levervc.com.Managing Partner Nick Cooney is the Co-Founder and former Managing Trustee of New Crop Capital, a private venture capital trust vehicle investing in the alternative protein space, and is Co-Founder of the Good Food Institute, the world’s largest non-governmental organization working to grow the alternative protein space. The General Partners at Lever VC have deployed over $1.5 billion in capital over the past decade across a variety of sectors, including over thirty deals in the alternative protein space.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $700k–$8.1M; Pre-Seed $500k–$850k; Series A $1.5M–$24M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- HerdDogg — HerdDogg is passionate about livestock. Its innovative data platform sits at the intersection of agtech, the internet of things, and global food security. Our patented DoggTags and DoggBone, together with our Animal Traceability Platform, help producers make more money from every animal they raise. The HerdDogg system enables animal tracking,welfare monitoring and traceability in an easy-to-use application. For more information, visit herddogg.com.
- XOXO Soda — XOXO Soda is a plant-based drink with prebiotic fiber that is low in sugar and calories.
- Melt&Marble — Melt&Marble, formerly known as Biopetrolia, was founded patent holding firm for co-founder Professor Jens Nielsen’s research group.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 68
- Round size: Seed $510k–$7M; Series A $2M–$68M; Series B $7M–$150M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!
Show more...Investment focus
- Industry: Medical, Biotechnology, Fashion
- Stage:Seed, Pre-Seed
- Geography: United States, Hong Kong
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Ascendant Dx — Choose An Online Slot Game
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
- BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 223
- Round size: Seed $120k–$4M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Living Models — Living Models is concentrating on this field by employing AI methods on biological data, especially in plant science, where enhancing crop yield and resilience is becoming crucial as global agriculture is impacted by climatic challenges.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Hong Kong, India
Investor stats
- Total investments: 123
- Round size: Seed $2M–$15M; Series A $6M–$37M; Series B $15M–$58M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Liquid AI — Liquid AI is an MIT spin-off with a presence in Boston, MA, and Palo Alto, CA. Our mission is to build state-of-the-art, general-purpose AI systems from first principles and deploy capable, efficient, highly aligned, and trustworthy AI for all.
- Gallant — Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.The company offers services that include retrieving valuable stem and regenerative cells, enabling pet owners to preserve their pet's young stem, and use them in treatment when necessary.Gallant Pet was established in 2018 by Aaron Hirschhorn andis headquartered in San Diego, California.
- Near Space Labs — Near Space Labs delivers high-resolution, 7cm orthoimagery at scale through our proprietary, stratospheric data capture platform.
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $1.3M–$7.5M; Series A $6M–$46M; Series B $15M–$226M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Change Bio — Change Bio converts waste methane into proteins to make them more affordable and carbon-negative.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
FHB Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Hong Kong, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
PT Medion is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Whist Subholdings is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.
Show more...Investment focus
- Industry: Biotechnology, Solar, Energy
- Stage:Seed, Angel, Series A
- Geography: Hong Kong, China
Investor stats
- Total investments: 6
- Round size: Seed $2M–$13M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- GenEditBio — GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.
- Immuno Cure — Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies for cancer, inflammatory, and infectious disorders.
- BioMed Technology Holdings — BioMed develops a personalized intestinal treatment plan with probiotics, a series of probiotic products for adults and children, to solve problems such as moisture sensitivity, detoxification, weight loss, emotional stress, etc., recommend the best adult and children probiotics for you, buy now!
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 72
- Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Coent Venture Partners provides seed and venture-stage funding to brilliant entrepreneurs and companies across all sectors in Asia. The company backed these entrepreneurs and companies with unparalleled support in funding, management, overseas business development, and exposure to their network.
Show more...Investment focus
- Industry: Apps, SaaS, Travel
- Stage:Seed, Series A
- Geography: Taiwan, China, Hong Kong
Investor stats
- Total investments: 4
- Round size: Seed $275k–$800k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QLL — QLL (Quick Language Learning) Pte. Ltd. is a company specialized in developing language learning apps, they are based in Taiwan and registered in Singapore. 2007, they launched a break-through Chinese learning gadget, “Pocket Chinese Tutor”, it is an Mp4 player with Chinese speech assessment function, it can help learner correct their accent ofspeaking Chinese.
- Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
- HelloWings — "See" the cheapest fare, year-round and fees included. Customized combination tickets. HelloWings ensures you'll arrive to destination on budget & in style.
FutureX Capital is an investment firm.
Show more...Investment focus
- Industry: Artificial Intelligence, Manufacturing, Health Care
- Stage:Seed, Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 36
- Round size: Seed $3.2M–$14M; Series A $10M–$43M; Series B $6.1M–$110M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Dify.AI — Unlock agentic workflow with Dify. Develop, deploy, and manage autonomous agents, RAG pipelines, and more for teams at any scale, effortlessly.
- Fuan Intelligent — Fuan Intelligent is an AI-powered materials science research platform developer that specializes in the deep integration of AI algorithms with materials simulation technologies.
- SeeYA Technology — SeeYA Technology is a high-tech company specializing in R&D, design, production and sales of new-generation semiconductor OLEDoS display, and providing customers with micro-display components, modules and related solutions. There is a comprehensive product line to full fill different demands from AR/VR, drones, thermal devices, nightvision equipment etc.
Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of agingLongevity Vision Fund provides Seedto Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, Hong Kong, Isle of Man
Investor stats
- Total investments: 21
- Round size: Series B $37M–$230M; Series C $65M–$300M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Biolinq — Introducing a revolutionary platform for metabolic health.
- Senda Biosciences — We work at the frontier of programmable medicines. We power our bioplatform and product candidates by harnessing evolution and AI. We operate with purpose and urgency on behalf of people everywhere. We aim to generate life-changing impact for the world.
- Tessera Therapeutics — Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine,building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: China, United States, Israel
Investor stats
- Total investments: 20
- Round size: Seed $750k–$4.5M; Series A $213k–$10M; Series B $10M–$150M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
- Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
We take a diversified approach, investing in the early stage, across multiple sectors with our deep domain expertise.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Taiwan, China
Investor stats
- Total investments: 148
- Round size: Seed $1.1M–$5M; Series A $2M–$15M; Series B $6M–$41M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $174M in 2016
Portfolio highlights
- DivX — Download free DivX Software to play, convert and cast video including DivX, AVI, MKV and HEVC files up to 4K. Play AVI and convert to MP4!
- Ultriva — Ultriva is a lean manufacturing software that enables you to adapt quickly and deliver impressive results. Experience modern lean manufacturing now. Learn more.
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
208 Seed Ventures provides early-stage investments in frontier technologies. 2SV brings Midwestern leaders, investors, and operators together and invests in startups pushing current technological limits. Their network provides smart capital and resources for companies with big ideas to accelerate growth.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
ETP Ventures
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Angel, Series A
- Geography: China, Hong Kong
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- SEIMEI — SEIMEI is a nutrition and anti-aging biotechnology brand.
- Dima Biotech — DIMA uses HEK293 mammalian cell expression system to produce many druggable proteins especially membrane proteins. This will not only ensure the authentic
- Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Provides growth equity to market leading companies in the United States and China
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: United States, Japan, Singapore
Investor stats
- Total investments: 73
- Round size: Series A $6M–$90M; Series B $18M–$723M; Series C $35M–$255M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $50M in 2018
Portfolio highlights
- Rebellions — AI chip architects are often inattentive to advanced deep learning features and requirements because they believe software stacks between their silicon and algorithms can provide effective abstract layers. We disagree. We do not think such naively designed chips can efficiently utilize expensive custom silicon resources. The more native hardwaresupports are enabled, the higher performance is achieved.Rebellions Inc is building genuine AI accelerators by bi-directionally bridging the gap between underlying silicon architectures and deep learning algorithms. We push algorithm boundaries to better exploit silicon budgets, while re-architecting AI processors to incorporate sophisticated deep learning features through silicon-dedicated DL kernels.Our goal is to deliver a domain-specific AI processor along with its optimized software. This approach, together with our unique decentralized programming model, will enable customers to arm with the most powerful yet energy-efficient AI hardware as well as seamless integration.
- Lhoopa — Making homeownership achievable for every Filipino family.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
The International Medical is an investment firm
Show more...Investment focus
- Industry: Medical, Hospitality, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BioMed Technology Holdings — BioMed develops a personalized intestinal treatment plan with probiotics, a series of probiotic products for adults and children, to solve problems such as moisture sensitivity, detoxification, weight loss, emotional stress, etc., recommend the best adult and children probiotics for you, buy now!
Apis Partners LLP backs growth financial services innovators who create transformative impact in their communities.
Show more...Investment focus
- Industry: Financial Services, Payments, FinTech
- Stage:Private Equity, Series B
- Geography: India, South Africa, Hong Kong
Investor stats
- Total investments: 42
- Lead/follow: no public data
Portfolio highlights
- KPay — KPay is a financial technology company that provides comprehensive payment collection solutions to SME merchants. It helps businesses streamline management processes and improve customer retention, business efficiency, and flexibility. KPay creates a more intuitive approach to running a business that enables merchants to reach their maximumpotential.
- Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
- MNT-Halan — MNT-Halan is a microfinance lending and payments company.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 194
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Series A
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Series A
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Human Longevity and Performance Impact Venture Fund is a longevity focused early-stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care. HLPIVF is establishing a synergisticecosystem of longevity and performance-focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Series A
- Geography: Hong Kong
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Empowering outstanding entrepreneurs across Southeast Asia in creating the next defining technology companies.
Show more...Investment focus
- Industry: E-Commerce, Financial Services, Software
- Stage:Seed, Series A, Series B
- Geography: Indonesia, Singapore, Vietnam
Investor stats
- Total investments: 69
- Round size: Seed $1M–$6M; Series A $4M–$12M; Series B $4M–$60M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $150M in 2015
Portfolio highlights
- FR8Labs — FR8Labs offers a practical freight forwarder solution that includes all of the modules required, without the extraneous trappings of overly sophisticated features that may not use but wind up paying for.
- Saladin — Saladin is an online platform that provides life, health, automotive, and travel insurance services.
- Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.
Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.
Show more...Investment focus
- Industry: Biotechnology, Sports, Boating
- Stage:Seed, Series A, Series B
- Geography: Hong Kong, China, Macao
Investor stats
- Total investments: 11
- Round size: Seed $2.5M–$5.1M; Series A $7M–$15M; Series B $14M–$28M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Realeague — Realeague is an organizer of sports entertainment designed to establish a cross-league basketball tournament in East Asia.
- SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
- Scolioscan — Scolioscan focuses on medical imaging technology research & development, self-service production and technology distribution and promotion.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more...Investment focus
- Industry: FinTech, Financial Services, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Hong Kong, Singapore
Investor stats
- Total investments: 74
- Round size: Seed $547k–$5.3M; Series A $1M–$37M; Series B $12M–$70M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 45
- Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $250M in 2015
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Capital Union Investments is a leader in private investment for early stage, growth, mezzanine, and pre-IPO capital. Headquartered in Hong Kong; and with offices in China and the US, the Firm's investment philosophy has been to create value by identifying leaders and innovators, whose businesses that can be developed in Asia. Our approach ofproviding unique investment insights, local knowledge and value-added operating capabilities, differentiates us from many traditional private investment funds.
Show more...Investment focus
- Industry: SaaS, Genetics, Software
- Stage:Seed, Series A
- Geography: Hong Kong, United States
Investor stats
- Total investments: 3
- Round size: Seed $2M–$10M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bringhub — Bringhub is a contextual marketing platform that enables digital media and marketers to drive product discovery and sales. We have developed the most comprehensive contextual analysis and optimization engine on the market. We call it Sweeten.
- Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
- Dash Living — Dash Living offers rental services and solutions for urban professionals. Dash offers panoramic all-inclusive rental options across over 1,000 units that they manage. Their mission is to create a global accommodation community through sharing economies and tech, empowering today's hyper-mobile, tech-savvy millennials to live in the expensivecities in the world.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Agriculture, Food and Beverage, Biotechnology
- Stage:Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 190
- Round size: Series A $4M–$47M; Series B $5.9M–$100M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Sentera — Sentera powers faster and more agronomic decisions with industry-leading solutions for data collection, analytics, and data modeling.
- Solarea Bio — Solaria Bio is redefining aging with nature-backed, science-driven solutions. Using powerful fruit and vegetable microbes, we support better bone health and overall well-being. Backed by cutting-edge research, we're here to help you age with strength and confidence. Learn more at solaria.bio.
- Bluestar Energy Capital — Bluestar Energy Capital is focused on addressing energy transition. Through a combination of establishing our own regional development platforms as well as controlling investments in existing platforms, our mission is to be one of the largest investors of project development capital globally.
WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team
Show more...Investment focus
- Industry: Biotechnology, Health Care, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, France, Denmark
Investor stats
- Total investments: 20
- Round size: Seed $3.3M–$20M; Series A $6.3M–$53M; Series B $24M–$50M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
- Clever Carnivore — Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets.
Join the movement toward democratised private markets, where investing is open to everyone. Discover a range of vetted tech investments, embodying the spirit of innovation in Web3, FinTech, AI, and ESG. Transform your investment strategy for a smarter, more sustainable future.
Show more...Investment focus
- Industry: FinTech, Software, Blockchain
- Stage:Seed, Series A, Pre-Seed
- Geography: Hong Kong, United States, Israel
Investor stats
- Total investments: 21
- Round size: Seed $1.1M–$5M; Pre-Seed $1.5M–$2.3M; Series A $3M–$4M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Tulle — NeoSwap is a multi-party, multi-item NFT swap platform that redistributes items in a win-win-win manner, using minimal currency. It provides neo-barter solutions to unlock value within existing marketplaces and enable marketplaces where they were previously unsustainable. It was founded by John Ennis.
- Antiverse — Designing biologics for 100 challenging targets
- Nufi — At Nufi we provide modular building blocks (or legos) that you can connect together to quickly create your own solutions. We take care of all of the technical and regulatory complexities so that you can focus on bringing your products to reality. We are the legos of fintech and our goal is to empower everyone to build financial products.
Ping An Insurance Company is a holding company deals with insurance, banking, and financial service.
Show more...Investment focus
- Industry: Health Care, FinTech, Finance
- Stage:Series A, Series E
- Geography: China, United States, Japan
Investor stats
- Total investments: 28
- Round size: Series A $1.4M–$300M; Series E $7.1M–$200M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Lixiangjia — The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high networth families. Professional overseas asset reconfiguration plan.
- Biren Technology — Biren Technology is a high-tech startup that has the niche in softwares, hardwares, and chip system.The niche software department is led by the industry's top talents, composed of field technical experts and software elite engineers. The niche hardware department is committed to building a wide range of computing solutions based on generalcomputing, combining versatility and specificity.As a frontier research department of the niches, the Institute aims to study the key technologies of new intelligent computing systems, focusing on new architectures and advanced compilation technologies.
- Hangzhou Yingde Gas — Hangzhou Yingde Gas is a company that specializes in the manufacturing and sales of industrial automatic control system devices and electrical signal equipment.
With more than 30 portfolio companies across AI, pet health, ageing medicine and more, LongeVC provides venture capital for the biotech and longevity sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Seed, Series A
- Geography: United States, Canada, Estonia
Investor stats
- Total investments: 13
- Round size: Seed $1.5M–$7M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- Proton Intelligence — Continuous, real-time, and accurate biomarker monitoring to better manage chronic disease and save lives.
- Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Hong Kong, United States, Singapore
Investor stats
- Total investments: 22
- Round size: Seed $1.2M–$5.5M; Series A $1M–$6.9M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Finquest — Tap into the largest private company database in the world to change the way you find and connect with M&A targets using Data, AI, & People.
- MediConCen — MediConCen is a medical network that mobilize medical experts all over the world to serve the insured population without middleman. They revolutionize the current medical network with Blockchain technology. MediConCen liberalizes the existing heavily walled medical network with the use of Blockchain technology, allowing individual clinics to rejointhe insurance market with a one-stop solution. The next generation medical ecosystem starts right here.MediConCen aims to integrate all clinics, insured employees and business entities into a unified Blockchain ecosystem, making business truly efficient, transparent and trustworthy.
- Crown Digital — Crown Digital harnesses the future-ready power of robotics and Artificial Intelligence to open doors with cutting-edge solutions for the not-so-distant future.
ASBV focuses on early and mid-term venture capital investments.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China, Australia, Hong Kong
Investor stats
- Total investments: 27
- Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$31M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 10
- Round size: Series B $3.4M–$9.9M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
- Heranova Lifesciences — Hekaiwei is a provider of innovative solutions for women's health.
- Precision Autoimmune Therapeutics — Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.
Show more...Investment focus
- Industry: E-Commerce, Financial Services, Internet
- Stage:Series A, Seed, Series B
- Geography: China, Malaysia, Singapore
Investor stats
- Total investments: 205
- Round size: Seed $800k–$7M; Series A $1.5M–$20M; Series B $5.5M–$37M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $1.3B in 2023
Portfolio highlights
- Fastwork — Founded in 2015 by a group of engineers and entrepreneurs from Silicon Valley and New York, Fastwork is one of the largest professional freelancing platforms in Southeast Asia by number of users and projects completed.Fastwork started with a mission to improve the business and employment economies in Southeast Asia, by making it simple, quick,and cost-effective for all types of businesses to find and hire freelancers to accelerate their growth.More than 300,000 businesses across Southeast Asia use Fastwork for its 22,000 services ranging from graphic design, online & influencer marketing, data entry, to web & app development.Fastwork also helps freelancers collect payments, promote their services, manage their orders, exchange files and communicate with their clients anywhere, anytime.
- viAct — viAct optimises construction safety, productivity and environmental compliance. Ensuring higher ESG preposition with AI. Offering services for construction industry of Asia & Europe & operational in China, Singapore, Japan, Australia, Vietnam, Indonesia and Hong Kong.
- KICKS CREW — KicksCrew provides everyone globally with a trusted source and the widest selection of sneakers and streetwear needs. From Newest Drops, Classics, Rare collectibles to Sports Needs.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$142M; Series B $14M–$230M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Biopharma
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Hong Kong
Investor stats
- Total investments: 39
- Round size: Seed $1.3M–$12M; Series A $17M–$61M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
- cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
- Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Debt Financing
- Geography: United States, Hong Kong, Isle of Man
Investor stats
- Total investments: 13
- Round size: Series A $3M–$19M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
- MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
- Souvien Therapeutics — Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series A, Series B, Seed
- Geography: China, Singapore, Norway
Investor stats
- Total investments: 71
- Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
- Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
- HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
Merrill Lynch Wealth Management has the financial advisors and expertise to help you achieve your goals at any stage of your life or career.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Series B, Series C
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 88
- Round size: Series B $10M–$80M; Series C $10M–$85M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- ITM Power — ITM manufacture PEM electrolysers. A pioneering technology that generates green hydrogen enabling customers to decarbonise.
- Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
- The Boeing Company — Welcome to the official corporate site for the world's largest aerospace company and leading manufacturer of commercial jetliners and defense, space and security systems. Learn about our passion for innovation, our products, careers and more.
A US$60M startup fund aiming at revitalizing HK’s ecosystem of innovation by connecting local venture capitalists and entrepreneurs to invest in ideas and startups. It is co-founded by Hony Capital, eGarden Ventures & several successful HK entrepreneur
Show more...Investment focus
- Industry: Information Technology, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: China, Hong Kong, Canada
Investor stats
- Total investments: 24
- Round size: Seed $720k–$3M; Series A $1.6M–$138M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Chaomu Technology — Chaomu Technology is a high-tech research and development enterprise dedicated to solving difficult human eye diseases. The company provides medical intelligent high-tech equipment and solutions. The pursuit of super purpose is to alleviate the increasing sub-light suffering of eye disease patients worldwide in a more scientific manner and torealize the dream of returning hundreds of millions of eye disease patients to a bright world.
- YAS — Every Moment Matters!YAS MicroInsurance is a Hong Kong-based next-generation InsurTech company to reshape the industry with simple, affordable, flexible MicroInsurance products tailored to customer’s needs.Built on innovative technology, YAS provides on-demand MicroInsurance products that activate protection for you anywhere and anytime on theYAS app. Whether it is your daily ride to work, a hike in the mountains, or a trip to the vet with your furbaby, we care about each moment in your life. YAS Microinsurance is redefining insurance. Simple, affordable, efficient, and coverage you control at your fingertips anytime, anywhere.
- GOGO Digital Innovation — GOGO Digital Innovation is a trendy digital asset art collection platform.
Founded in 2015, A-Level Capital is a student-run venture capital firm that aims to empower Johns Hopkins University's entrepreneurial community through funding and support.
Show more...Investment focus
- Industry: Health Care, Medical, SaaS
- Stage:Seed, Series A
- Geography: United States, Hong Kong
Investor stats
- Total investments: 18
- Round size: Seed $100k–$4.6M; Series A $2.8M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Order — Modernize your procure-to-pay process with Order.co. Automate purchasing & payments to help your business save time, save money, and gain clarity.
- Siren Care — Siren Socks help reduce the risk of foot ulcers for patients with diabetes through the early detection of potential injuries.
- Leap AI — Humanize AI-generated text to read naturally and pass the major detectors. Free detection, no signup.
China Venture Capital is a venture capital industry trade group.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Angel, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 49
- Round size: Angel $425k–$425k; Series B $2.6M–$72M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Moptim — Moptim is a global medical technology innovator committed to introduce high technology and ophthalmic product solution at affordable price.
- Rabbitpre — Rabbitpre is a big data-driven technology marketing company.
- Reprogenix — Reprogenix is a groundbreaking medical technology firm that began with stem cell therapy for diabetes and is dedicated to expanding the use of cell therapy in a wide range of disease areas.
Good Startup exists to remove animals from the food system.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 13
- Round size: Seed $1.9M–$12M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $34M in 2022
Portfolio highlights
- BioRaptor — BioRaptor is a bioprocessing data analytics platform that automatically captures and organizes contextualized data in one place, and provides you with instant analyses results and actionable insights. It makes collaboration and reportig easy through its automated reports, graphs and dashobards, and helps prevent run failures with remote monitoring capabilities.
- New School Foods — Salmon, made from plants. Clean label with ALL the Omega-3s, NONE of the mercury. Made in Canada.
- Standing Ovation — Animal-free dairy cheese
Biotechnology VC funding in Hong Kong at a glance
Stats across 47 deals from 106 investors.
Access all 106 VC funds in Hong Kong Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 106 VC funds investing in Hong Kong Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!